Retension Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateGlobeNewsWire • 12m
Retension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation ConferenceGlobeNewsWire • 11/05/26
U.S. IPO Weekly Recap: Biotech IPOs Keep Flowing As Data Center Developer DayOne Joins The PipelineSeeking Alpha • 10/10/26